Pages that link to "Q29619876"
Jump to navigation
Jump to search
The following pages link to Cocaine receptors on dopamine transporters are related to self-administration of cocaine (Q29619876):
Displaying 50 items.
- Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs (Q21262013) (← links)
- D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims (Q22010414) (← links)
- Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research (Q22241485) (← links)
- Plasma membrane monoamine transporters: structure, regulation and function (Q22251021) (← links)
- Candidate gene studies of ADHD: a meta-analytic review (Q22252698) (← links)
- Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1 (Q24291215) (← links)
- Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter (Q24296225) (← links)
- Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter (Q24310836) (← links)
- Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities (Q24336539) (← links)
- Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter (Q24548521) (← links)
- Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum (Q24557423) (← links)
- Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age (Q24564422) (← links)
- Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primates (Q24605771) (← links)
- Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity (Q24616099) (← links)
- Influence of chronic dopamine transporter inhibition by RTI-336 on motor behavior, sleep, and hormone levels in rhesus monkeys (Q24616981) (← links)
- How addictive drugs disrupt presynaptic dopamine neurotransmission (Q24631269) (← links)
- Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter (Q24644993) (← links)
- 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors (Q24645072) (← links)
- Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse (Q24647662) (← links)
- Role of monoamine transporters in mediating psychostimulant effects (Q24647948) (← links)
- The binding sites for cocaine and dopamine in the dopamine transporter overlap (Q24650126) (← links)
- Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey (Q24651855) (← links)
- Kappa-opioid ligands in the study and treatment of mood disorders (Q24657982) (← links)
- Actions of cocaine on rat dopaminergic neurones in vitro (Q24673575) (← links)
- Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys (Q24685831) (← links)
- Ventral Tegmental Area Afferents and Drug-Dependent Behaviors (Q26751118) (← links)
- Impact of cocaine abuse on HIV pathogenesis (Q26779435) (← links)
- Insights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDAT (Q26781554) (← links)
- Presynaptic dopamine modulation by stimulant self-administration (Q26823507) (← links)
- Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter (Q26829749) (← links)
- Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates (Q26853319) (← links)
- Nitric Oxide-GAPDH Transcriptional Signaling Mediates Behavioral Actions of Cocaine (Q27009552) (← links)
- Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine (Q27013928) (← links)
- Agonist replacement for stimulant dependence: a review of clinical research (Q27014854) (← links)
- Neuroimaging for drug addiction and related behaviors (Q27014859) (← links)
- Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder (Q27015917) (← links)
- Initial d2 dopamine receptor sensitivity predicts cocaine sensitivity and reward in rats (Q27303496) (← links)
- Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area (Q27320220) (← links)
- Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers (Q27325489) (← links)
- Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations (Q27863301) (← links)
- Excited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric Continuum (Q28076564) (← links)
- Agonist Medications for the Treatment of Cocaine Use Disorder (Q28087404) (← links)
- Glutamatergic transmission in drug reward: implications for drug addiction (Q28112161) (← links)
- A cocaine analog, 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT), reduces tyrosine hydroxylase in the mesolimbic dopamine pathway (Q28143101) (← links)
- Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin (Q28143430) (← links)
- Pharmacotherapies for cocaine dependence (Q28174772) (← links)
- Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum (Q28178494) (← links)
- Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review (Q28185910) (← links)
- Chronic cocaine self-administration upregulates the norepinephrine transporter and alters functional activity in the bed nucleus of the stria terminalis of the rhesus monkey (Q28201878) (← links)
- Locomotor stimulant effects of novel phenyltropanes in the mouse (Q28206079) (← links)